Responses
Immunotherapy biomarkers
Original research
Extensive-stage small-cell lung cancer in patients receiving atezolizumab plus carboplatin–etoposide: stratification of outcome based on a composite score that combines gene expression profiling and immune characterization of microenvironment
Compose a Response to This Article
Other responses
No responses have been published for this article.
